Keshmiri Mohammad Sadegh, Aghdasi Sina, Noorali Sima, Shafaghi Shadi, Serati Alireza, Naghashzadeh Farah, Movahed Mohammad Reza, Shadanfar Sharare, Hajimoradi Maryam, Kashani Babak Sharif
Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Medicine, University of Arizona, Phoenix, Arizona.
Int J Angiol. 2022 May 19;33(4):307-314. doi: 10.1055/s-0042-1745839. eCollection 2024 Dec.
After the outbreak of the novel coronavirus at the end of December 2019 in China, it has become a global pandemic. Clinical manifestation of coronavirus disease 2019 (COVID-19) has a wide range of presentations from asymptomatic to severe multi-organ involvement. Hemoptysis appears to be one of the major manifestations of severe acute respiratory syndrome that is related to COVID-19 infection. The occurrence of hemoptysis is multifactorial. However, massive hemoptysis is usually related to pulmonary aspergillosis or severe bronchiectasis due to corticosteroid pulse therapy that can be life-threatening. This manuscript presents five cases of successful life-saving bronchial artery embolization in patients with COVID-19 infection who were suffering from massive hemoptysis that was mostly related to aspergillosis and bronchiectasis. These cases are followed by a review of the literature.
2019年12月底新型冠状病毒在中国爆发后,它已成为全球大流行疾病。2019冠状病毒病(COVID-19)的临床表现范围广泛,从无症状到严重的多器官受累。咯血似乎是与COVID-19感染相关的严重急性呼吸综合征的主要表现之一。咯血的发生是多因素的。然而,大量咯血通常与肺曲霉病或因皮质类固醇脉冲治疗导致的严重支气管扩张有关,这可能危及生命。本文报告了5例COVID-19感染患者成功进行挽救生命的支气管动脉栓塞术的病例,这些患者患有大量咯血,主要与曲霉病和支气管扩张有关。这些病例之后是文献综述。